Epitomee Medical is a drug-free, self-administered shapeshifting capsule, for inducing weight loss and preventing diabetes
Epitomee has raised €7.1M across 1 funding round from 1 investor, most recently a round in Apr 2019. Based in Caesarea, Israel; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-04-01 | Other | €7.1M |
| XT Hi-Tech |
| View deal → |
